Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

Eisai

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Eisai's 2012 sales performance.

Holding on to hope for Alzheimer’s advances

Holding on to hope for Alzheimer’s advances

Leading the pack are Merck &Co’s verubecestat, pivotal data on which is due in mid-2017, Lilly and AstraZeneca’s LY3314814 and Eisai/Biogen’s E2609.

Merck BACE inhibitor adds to litany of Alzheimer's trial failures

Merck BACE inhibitor adds to litany of Alzheimer's trial failures Interim data shows “virtually no chance” of clinical success for verubecestat

AbbVie takes anti-tau drug into phase II for Alzheimer's

AbbVie takes anti-tau drug into phase II for Alzheimer's Other companies working on tau include Eisai/Biogen who are looking at combining a tau blocker with an anti-amyloid drug, as well as Bristol-Myers Squibb, AC Immune, Axon Neuroscience

Eisai takes control of weight loss drug Belviq from Arena

Eisai takes control of weight loss drug Belviq from Arena Frustrated with lacklustre sales growth, Eisai has bought global rights to weight-loss drug Belviq from its originator Arena Pharmaceuticals. ... Eisai has already invested considerable effort and resources in the drug and clearly decided it can do

NICE backs Eisai's Halaven for breast cancer

NICE backs Eisai's Halaven for breast cancer NICE backs Eisai's Halaven for breast cancer. Reverses 2012 rejection due to new data and patient access discount. ... NICE has given a green light to Eisai's third-line breast cancer therapy Halaven, reversing its 2012 rejection of the drug.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Streaming Well

Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics